Search Results

100 hits for »HTA «

PharmaBoardroom Opinion: New EU HTA Procedure - Will it Reduce the Complexity and Burdens for Manufacturers?

…a number of issues the new EU HTA procedure was meant to tackle[1], the most important being divergent HTA processes and methodologies in Member States and the duplication of work for national HTA bodies and developers. Together, these issues impede and distort market access and…

https://www.eucope.org/pharmaboardroom-opinion-new-eu-hta-procedure-will-it-reduce-the-complexity-and-burdens-for-manufacturers/

EUCOPE/EFPIA Joint Statement: Concerns over the implementation of the EU HTA Regulation

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA

https://www.eucope.org/eucope-efpia-joint-statement-eu-hta-regulation/

EVENT RECAP - Life Science Lectures: Episode Three "‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’

…as possible guidance on (High) Unmet Needs and how this relates to EU-level and national level HTA work. According to van den Steen, “A well-coordinated relationship between the Pharmaceutical Package and HTA is essential for success”. According to van den Steen, the EU HTA procedure…

https://www.eucope.org/event-recap-life-science-lectures-episode-three-eu-hta-how-will-the-revised-pharma-package-impact-the-value-assessment-of-therapies/

Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity to speed up access to innovative medicines for European patients

…draft Implementing Act for the new EU HTA procedure. The draft Implementing Act (IA) on Joint Clinical Assessment (JCA) of medicinal products, prepared by Member States’ “Comitology” Committee on Health Technology Assessment (HTA) with the support of the European Commission, has recently been published for…

https://www.eucope.org/life-science-industry-concerns-over-the-workability-of-eu-hta-europe-cannot-miss-out-on-the-opportunity-to-speed-up-access-to-innovative-medicines-for-european-patients/

DIA HTA Forum 2023

…EU HTA Regulation: Preparing for a Changing Landscape 25 September | Industry Only Dive into the EU HTA Regulation landscape at the DIA HTA Forum’s Pre-Forum Workshop, exclusive for industry attendees. Explore strategies for navigating the complexity of future Joint Clinical Assessments (JCAs) and for…

https://www.eucope.org/events/dia-hta-forum-2023/

‘Piloting the EU HTA before 2025 – Opportunities for companies to engage’

…will be made subject to the EU HTA which pharmaceuticals will be subject to the EU HTA procedure starting in 2025 Don’t miss your opportunity to get ahead and fully understand the implications of the EU HTA system in 2025. Secure your free place here…

https://www.eucope.org/events/piloting-the-eu-hta-before-2025-opportunities-for-companies-to-engage/

?️Sounds of Science #12 on the new EU HTA Procedure

Sounds of Science – Episode 12 The new EU HTA Procedure: Getting it right to improve patients’ access to innovative therapies With the entry into force of the EU HTA Regulation in January 2022, the European Commission and EUnetHTA21, a consortium of Member States HTA

https://www.eucope.org/sounds-of-science-12-on-the-new-eu-hta-procedure/

EU HTA & EUnetHTA21 – The pathway for implementation of the EU HTA system in 2025 – helping companies prepare for submission

Join EUNetHTA, EUCOPE and MAP Patient Access as they discuss the implementation of the EU HTA system in 2025. This webinar will help attendees to: Understand details about the stepwise entry into force of the EU HTA starting in January 2025 Learn how EUnetHTA21 will…

https://www.eucope.org/events/eu-hta-eunethta21-the-pathway-for-implementation-of-the-eu-hta-system-in-2025-helping-companies-prepare-for-submission/

EUCOPE appointed to the new HTA Stakeholder Network

…the HTA Coordination Group. In this regard, members of the HTA Stakeholder Network will be involved in the activities listed in the Regulation, such as: Consultations in preparation or amendment of the HTA Coordination Group’s annual work programme (Article 6(3)(d) of the Regulation); Meetings with…

https://www.eucope.org/eucope-appointed-to-the-new-hta-stakeholder-network/

The Implications Of The New EU HTA Regulation For Companies

Joint Clinical Assessments Will Become A Key Part Of The New Environment Regulation (EU) 2021/2282 on health technology assessment (HTA) is now in force and will bring important and wide-reaching changes that pharmaceutical companies need to understand. Arguably the most important implication of the regulation…

https://www.eucope.org/the-implications-of-the-new-eu-hta-regulation-for-companies/